Edward C Burgard

Title: Edward C. Burgard: Innovator in Urological Treatments

Introduction

Edward C. Burgard is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of urology, particularly in the treatment of lower urinary tract disorders. With a total of 5 patents, his work has the potential to improve the quality of life for many patients suffering from these conditions.

Latest Patents

Burgard's latest patents include innovative methods for using ziconotide to treat overactive bladder. This invention focuses on utilizing Cav2.2 subunit calcium channel modulators to address both painful and non-painful lower urinary tract disorders, including vulvodynia and vulvar vestibulitis, in patients with normal and spinal cord injuries. Another significant patent involves thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders. This invention also employs Cav2.2 subunit calcium channel modulators to provide therapeutic benefits.

Career Highlights

Edward C. Burgard is currently associated with Dynogen Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective treatments for complex urological issues.

Collaborations

Burgard has collaborated with notable colleagues, including Matthew Oliver Fraser and Karl Bruce Thor. These partnerships have likely contributed to the innovative nature of his patents and the overall success of his projects.

Conclusion

Edward C. Burgard stands out as a dedicated inventor in the field of urology, with a focus on developing effective treatments for lower urinary tract disorders. His contributions through patents and collaborations reflect his commitment to improving patient care and advancing medical science.